Heartflow, Inc. - Common Stock (HTFL)
Healthcare › Surgical & Medical Instruments & Apparatus
Price History
Feb 9, 2026 — Jul 6, 2026Investment Snapshot
- P/B of 10.21 — trading above book value
- Piotroski F-Score 4/9 — moderate financial health
- Loss-making — negative ROE of -41.9%
- Revenue growing at 40% annually
Heartflow, Inc. - Common Stock (HTFL) is a Healthcare company operating in Surgical & Medical Instruments & Apparatus, listed on the NASDAQ , with a market capitalisation of $2.9 billion . Key value metrics: P/B ratio 10.21, Piotroski F-Score 4 out of 9 (moderate financial health) .
Value Score
Key Metrics
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Heartflow, Inc. - Common Stock — Fundamental Analysis Summary
On financial health, HTFL shows a moderate Piotroski F-Score of 4/9, and negative return on equity of -41.9% (sector average: -20.6%), and manageable leverage with a debt-to-equity ratio of 0.43.
StockPik's composite Value Score for HTFL is 32/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
HTFL reports a high gross margin of 77.0% (sector average: 39.4%) and a negative operating margin of -42.2%.
HTFL shows revenue growing at 40% year-over-year, with earnings declining at 21%.